John W. Ripple
Vorstandsvorsitzender bei Exonics Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sohang Chatterjee | M | - |
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | - |
| Pradip K. Majumder | M | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | - |
| Shawn Titcomb | M | - |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | 3 Jahre |
| Martin Lehr | M | 40 |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation. | 4 Jahre |
| Kathy Dalziel Howie | F | - |
Children's Melanoma Prevention Foundation
 Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Roger Perlmutter | M | 71 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | 6 Jahre |
| Ellen Callahan | F | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| J. J. Kang | M | - |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | - |
| Sara Mason Ader | F | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Tori DeMaio | F | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Anthony Drapos | M | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Richard Eisen | M | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Gus Naughton | M | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
| Lori Skinner | F | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | 15 Jahre |
| Jeremy Warhaftig | M | - |
Children's Melanoma Prevention Foundation
Children's Melanoma Prevention Foundation Miscellaneous Commercial ServicesCommercial Services Part of Melanoma Research Foundation, Children's Melanoma Prevention Foundation is a non-profit educational foundation that provides video lessons and programs to educate and prevent skin cancer. The company is based in Hingham, MA. The company was founded in 2003. Children's Melanoma Prevention Foundation was acquired by Melanoma Research Foundation on November 02, 2021. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Steinmetz | M | 75 |
Virdante Pharmaceuticals, Inc.
 Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
| Anders Hove | M | 58 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | 8 Jahre |
| Leonard Patrick Gage | M | 81 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
| Raymond Kubacki | M | 79 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | 1 Jahre |
| Eric Aguiar | M | 62 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
| Gail Folena-Wasserman | M | 69 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
| Jeffrey V. Ravetch | M | 73 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
| Cristina Csimma | M | 65 |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | 2 Jahre |
| Rajeev Chillakuru | M | - |
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 24 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- John W. Ripple
- Persönliches Netzwerk
